Noori et al Obituary – Cause of Death : 2023 Study Shows Ivermectin Treats MS in Mice

death – obituary– Cause of Death News : to the dignity and memory of the deceased.

In the latest groundbreaking research, Iranian scientists have discovered that Ivermectin, a widely used anti-parasitic medication, may hold the key to treating Multiple Sclerosis (MS). Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system, causing inflammation, damage to the myelin sheath, and ultimately leading to disability.

The study, conducted by Noori et al in 2023, focused on the anti-inflammatory action, neuroprotective effects, and re-myelination properties of Ivermectin in a mouse model of MS. The researchers found that Ivermectin not only reduced inflammation in the central nervous system but also promoted the regeneration of damaged myelin, the protective covering of nerve fibers.

These findings are significant as current treatments for MS mainly focus on managing symptoms and slowing disease progression, rather than repairing damage to the nervous system. Ivermectin’s ability to target both the inflammatory response and promote re-myelination offers new hope for patients with MS.

Furthermore, Ivermectin is already approved by the FDA for the treatment of parasitic infections in humans, making it a promising candidate for repurposing in the treatment of MS. Its safety profile and low cost compared to other MS medications also make it an attractive option for further clinical trials.

While the study was conducted in mice and further research is needed to confirm these findings in humans, the potential of Ivermectin in treating MS is a promising development in the field of neurology. With more research and clinical trials, Ivermectin could become a game-changer in the treatment of Multiple Sclerosis, offering new hope for patients living with this debilitating disease.

Stay tuned for updates on this exciting new research and its implications for the future of MS treatment.